| Brad Steenwyk, M.D. |
|
|
|
Associate Professor This e-mail address is being protected from spambots. You need JavaScript enabled to view it 205-934-7424 Clinical Subspecialty and Area(s) of Interest · Cardiothoracic Anesthesia Education and Degrees · University of Alabama at Birmingham School of Medicine, Medical Doctor, 1999 · Baptist Health Systems, Internal Medicine Internship, 2000 · University of Alabama at Birmingham School of Medicine, Anesthesiology Residency, 2003 Recent Publications (in last 5 years) · Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. J Heart Lung Transplant. 2006 Jun;25(6):653-63 · Nielsen VG, Steenwyk BL, Gurley WQ. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII. J Heart Lung Transplant. 2006 Oct;25(10):1247-52 · Nielsen VG, Audu P, Cankovic L, Lyerly RT 3rd, Steenwyk BL, Armstead V, Powell G. Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg. 2007 Jan;104(1):59-64 · Nielsen VG, Cankovic L, Steenwyk BL. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul Fibrinolysis. 2007 Jan;18(1):35-9 · Steenwyk BL, Kirklin JK, Gurley WQ, Nielsen VG. The hemostatic history of a 15-month-old child implanted with a Berlin heart left ventricular assist device. Anesth Analg. 2007 Mar;104(3):538-40 |


